日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting the DDX3/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma

靶向DDX3/PAF1轴可增强胰腺导管腺癌的化疗疗效

Nallasamy, Palanisamy; Seshacharyulu, Parthasarathy; Rauth, Sanchita; Shah, Ashu; Marimuthu, Saravanakumar; Varadharaj, Venkatesh; Bommideni, Madhulatha; Mallya, Kavita; Alsafwani, Zahraa Wajih; Lele, Subodh M; Raman, Venu; Batra, Surinder K; Ponnusamy, Moorthy P

Targeting FOXM1 reshapes antitumor immunity to attenuate small cell lung cancer progression

靶向 FOXM1 可重塑抗肿瘤免疫,从而减缓小细胞肺癌的进展。

Khan, Md Arafat; Khan, Parvez; Fatima, Mahek; Rehman, Asad Ur; Anwar, Laiba; Alsafwani, Zahraa Wajih; Ahmad, Aatiya; Abbas Zaidi, Mohammad Ali; Cox, Jesse L; Zahid, Areem; Mohiuddin, Sameer; Kim, Sung Hoon; Santamaria-Barria, Juan A; Lakshmanan, Imayavaramban; Katzenellenbogen, Benita S; Katzenellenbogen, John A; Ganti, Apar K; Batra, Surinder K; Nasser, Mohd Wasim

Midkine (MDK) as a central regulator of the tumor microenvironment: From developmental cytokine to therapeutic target

中肾素(MDK)作为肿瘤微环境的核心调控因子:从发育细胞因子到治疗靶点

Nair, Hareesh B; Nair, Ajay; Liu, Ya-Guang; Vijayan, Dileep K; Subramani, Ramadevi; Lakshmanaswamy, Rajkumar; Viswanadhapalli, Suryavathi; Sareddy, Gangadhara R; Batra, Surinder K; Vadlamudi, Ratna K

Ixazomib triggers autophagic degradation of MUC5AC/integrin-β4 and inhibits non-small cell lung cancer progression.

伊沙佐米可触发 MUC5AC/整合素-β4 的自噬降解,并抑制非小细胞肺癌的进展。

Appadurai Muthamil Iniyan, Alsafwani Zahraa Wajih, Chaudhary Sanjib, Shah Ashu, Somavarapu Pranay, Dooshety Sriman N, Kubicek Ben S, Batra Surinder K, Lakshmanan Imayavaramban, Ganti Apar Kishor

Multifaceted role of primary cilia and ciliary proteins: A potential nexus for hedgehog signaling and prostate cancer

纤毛及其蛋白的多重作用:刺猬信号通路与前列腺癌的潜在联系

Kaushal, Jyoti B; Seshacharyulu, Parthasarathy; Batra, Surinder K; Muniyan, Sakthivel

Unveiling the gut-pancreas axis: microbial influence on stemness and tumor microenvironment of PDAC

揭示肠-胰轴:微生物对胰腺导管腺癌干细胞特性和肿瘤微环境的影响

Arikath, Kirtana; Batra, Surinder K; Ponnusamy, Moorthy P

Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer.

释放 CXCR2 抑制剂的强大作用,克服胰腺癌吉西他滨耐药性。

Molczyk Caitlin, Sturgeon Reegan, Saxena Sugandha, Johnson Esther, Bhatia Rakesh, Bhyravbhatla Namita, Kumar Sushil, Batra Surinder K, Singh Rakesh K

Contract to kill: GNAS mutation

杀手契约:GNAS 突变

Raut, Pratima; Mathivanan, Poompozhil; Batra, Surinder K; Ponnusamy, Moorthy P

Sugar symphony: glycosylation in cancer metabolism and stemness

糖的交响曲:癌症代谢和干细胞特性中的糖基化

Varadharaj, Venkatesh; Petersen, Wyatt; Batra, Surinder K; Ponnusamy, Moorthy P

PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer

PAF1介导的转录重编程赋予晚期前列腺癌多西他赛耐药性

Muniyan, Sakthivel; Vengoji, Raghupathy; Nimmakayala, Rama Krishna; Seshacharyulu, Parthasarathy; Perumalsamy, Balaji; Alsafwani, Zahraa Wajih; Kakar, Sham S; Smith, Lynette M; Shonka, Nicole; Teply, Benjamin A; Lele, Subodh M; Ponnusamy, Moorthy P; Batra, Surinder K